1 November 2022 false No description of principal activity Taxfiler 2023.10 14453039business:PrivateLimitedCompanyLtd2022-11-012023-10-31 144530392022-10-31 144530392022-11-012023-10-31 14453039business:AuditExemptWithAccountantsReport2022-11-012023-10-31 14453039business:FilletedAccounts2022-11-012023-10-31 144530392023-10-31 14453039business:Director12022-11-012023-10-31 14453039core:WithinOneYear2023-10-31 14453039core:ShareCapitalcore:PreviouslyStatedAmount2023-10-31 14453039core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-10-31 14453039core:PreviouslyStatedAmount2023-10-31 14453039business:SmallEntities2022-11-012023-10-31 14453039countries:EnglandWales2022-11-012023-10-31 14453039core:AfterOneYear2023-10-31 14453039business:OrdinaryShareClass12022-11-012023-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14453039 (England and Wales)
Jaycinth Medical Limited Unaudited accounts for the year ended 31 October 2023
Jaycinth Medical Limited Unaudited accounts Contents
Page
- 2 -
Jaycinth Medical Limited Company Information for the year ended 31 October 2023
Director
Jaycinth Elaine SHARPE
Company Number
14453039 (England and Wales)
- 3 -
Jaycinth Medical Limited Statement of financial position as at 31 October 2023
2023 
Notes
£ 
Current assets
Debtors
220 
Cash at bank and in hand
121 
341 
Creditors: amounts falling due within one year
(233)
Net current assets
108 
Net assets
108 
Capital and reserves
Called up share capital
100 
Profit and loss account
8 
Shareholders' funds
108 
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 November 2023 and were signed on its behalf by
Jaycinth Elaine SHARPE Director Company Registration No. 14453039
- 4 -
Jaycinth Medical Limited Notes to the Accounts for the year ended 31 October 2023
1
Statutory information
Jaycinth Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 14453039.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2023 
£ 
Amounts falling due after more than one year
Other debtors
220 
5
Creditors: amounts falling due within one year
2023 
£ 
Accruals
233 
6
Share capital
2023 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
7
Average number of employees
During the year the average number of employees was 1.
- 5 -